Yong-Heng Sui1, Wen-Jing Luo1, Qin-Yu Xu1, Jing Hua1. 1. Yong-Heng Sui, Wen-Jing Luo, Qin-Yu Xu, Jing Hua, Division of Gastroenterology and Hepatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai 200127, China.
Abstract
AIM: To investigate the effect of different dietary fatty acids on hepatic inflammasome activation. METHODS: Wild-type C57BL/6 mice were fed either a high-fat diet or polyunsaturated fatty acid (PUFA)-enriched diet. Primary hepatocytes were treated with either saturated fatty acids (SFAs) or PUFAs as well as combined with lipopolysaccharide (LPS). The expression of NOD-like receptor protein 3 (NLRP3) inflammasome, peroxisome proliferator-activated receptor-γ and nuclear factor-kappa B (NF-κB) was determined by real-time PCR and Western blot. The activity of Caspase-1 and interleukine-1β production were measured. RESULTS: High-fat diet-induced hepatic steatosis was sufficient to induce and activate hepatic NLRP3 inflammasome. SFA palmitic acid (PA) directly activated NLRP3 inflammasome and increased sensitization to LPS-induced inflammasome activation in hepatocytes. In contrast, PUFA docosahexaenoic acid (DHA) had the potential to inhibit NLRP3 inflammasome expression in hepatocytes and partly abolished LPS-induced NLRP3 inflammasome activation. Furthermore, a high-fat diet increased but PUFA-enriched diet decreased sensitization to LPS-induced hepatic NLRP3 inflammasome activation in vivo. Moreover, PA increased but DHA decreased phosphorylated NF-κB p65 protein expression in hepatocytes. CONCLUSION: Hepatic NLRP3 inflammasome activation played an important role in the development of non-alcoholic fatty liver disease. Dietary SFAs and PUFAs oppositely regulated the activity of NLRP3 inflammasome through direct activation or inhibition of NF-κB.
AIM: To investigate the effect of different dietary fatty acids on hepatic inflammasome activation. METHODS: Wild-type C57BL/6 mice were fed either a high-fat diet or polyunsaturated fatty acid (PUFA)-enriched diet. Primary hepatocytes were treated with either saturated fatty acids (SFAs) or PUFAs as well as combined with lipopolysaccharide (LPS). The expression of NOD-like receptor protein 3 (NLRP3) inflammasome, peroxisome proliferator-activated receptor-γ and nuclear factor-kappa B (NF-κB) was determined by real-time PCR and Western blot. The activity of Caspase-1 and interleukine-1β production were measured. RESULTS: High-fat diet-induced hepatic steatosis was sufficient to induce and activate hepatic NLRP3 inflammasome. SFA palmitic acid (PA) directly activated NLRP3 inflammasome and increased sensitization to LPS-induced inflammasome activation in hepatocytes. In contrast, PUFAdocosahexaenoic acid (DHA) had the potential to inhibit NLRP3 inflammasome expression in hepatocytes and partly abolished LPS-induced NLRP3 inflammasome activation. Furthermore, a high-fat diet increased but PUFA-enriched diet decreased sensitization to LPS-induced hepatic NLRP3 inflammasome activation in vivo. Moreover, PA increased but DHA decreased phosphorylated NF-κB p65 protein expression in hepatocytes. CONCLUSION: Hepatic NLRP3 inflammasome activation played an important role in the development of non-alcoholic fatty liver disease. Dietary SFAs and PUFAs oppositely regulated the activity of NLRP3 inflammasome through direct activation or inhibition of NF-κB.
Authors: Clare M Reynolds; Fiona C McGillicuddy; Karen A Harford; Orla M Finucane; Kingston H G Mills; Helen M Roche Journal: Mol Nutr Food Res Date: 2012-06-15 Impact factor: 5.914
Authors: Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti Journal: Proc Natl Acad Sci U S A Date: 2011-08-29 Impact factor: 11.205
Authors: Sena Kim; Yeonsoo Joe; Sun Oh Jeong; Min Zheng; Sung Hoon Back; Sang Won Park; Stefan W Ryter; Hun Taeg Chung Journal: Innate Immun Date: 2013-11-11 Impact factor: 2.680
Authors: Alison L Harte; Nancy F da Silva; Steven J Creely; Kirsty C McGee; Thomas Billyard; Elham M Youssef-Elabd; Gyanendra Tripathi; Esmat Ashour; Mohga S Abdalla; Hayat M Sharada; Ashraf I Amin; Alastair D Burt; Sudhesh Kumar; Christopher P Day; Philip G McTernan Journal: J Inflamm (Lond) Date: 2010-03-30 Impact factor: 4.981
Authors: Salvatore Carbone; Adolfo G Mauro; Andrea Prestamburgo; Matthew S Halquist; Pratyush Narayan; Nicola Potere; Eleonora Mezzaroma; Benjamin W Van Tassell; Antonio Abbate; Stefano Toldo Journal: J Cardiovasc Pharmacol Date: 2018-12 Impact factor: 3.105
Authors: Lisanne C Anders; Heegook Yeo; Brenna R Kaelin; Anna L Lang; Adrienne M Bushau; Amanda N Douglas; Matt Cave; Gavin E Arteel; Craig J McClain; Juliane I Beier Journal: Toxicol Appl Pharmacol Date: 2016-09-28 Impact factor: 4.219
Authors: S Carbone; P J H Lee; A G Mauro; E Mezzaroma; R Buzzetti; B Van Tassell; A Abbate; S Toldo Journal: Nutr Diabetes Date: 2017-04-10 Impact factor: 5.097
Authors: Sofia Kartsoli; Christina E Kostara; Vasilis Tsimihodimos; Eleni T Bairaktari; Dimitrios K Christodoulou Journal: World J Hepatol Date: 2020-08-27